03-0171-00
SMC® Human Brain-Derived Neurotrophic Factor (BDNF) High Sensitivity Immunoassay Kit
Used for ultrasensitive quantification of Human BDNF in human serum, plasma, and cerebrospinal fluid (CSF)
别名:
Abrineurin immunoassay kit, BDNF Single Molecule Counting Kit, BDNF ultra-sensitive immunoassay
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
NACRES:
NA.84
UNSPSC Code:
12161503
Technique(s):
single molecule counting: suitable
Usage:
kit sufficient for 96 wells
Compatibility:
for use with FemtoQuest™ and SMCxPRO® instruments
产品名称
SMC® Human Brain-Derived Neurotrophic Factor (BDNF) High Sensitivity Immunoassay Kit,
description
Used for ultrasensitive quantification of Human BDNF in human serum, plasma, and cerebrospinal fluid (CSF)
product line
SMC®
usage
kit sufficient for 96 wells
technique(s)
single molecule counting: suitable
input
serum
cerebrospinal fluid (CSF)
plasma (K2 EDTA)
UniProt accession no.
compatibility
for use with FemtoQuest™ and SMCxPRO® instruments
relevant disease(s)
Alzheimer′s disease
shipped in
wet ice
storage temp.
2-8°C
General description
Brain-Derived Neurotrophic Factor (BDNF) is a crucial protein involved in the development, maintenance, and survival of neurons in the brain. As a member of the neurotrophin family, BDNF promotes neuronal growth, differentiation, and synaptic plasticity, which are essential for learning and memory. It is primarily expressed in the brain, particularly in regions such as the hippocampus, cortex, and basal forebrain.
BDNF plays a significant role in neurological disorders and neurodegenerative diseases. Reduced levels of BDNF have been associated with conditions like Alzheimer′s disease, Parkinson′s disease, and depression. Low BDNF levels can lead to neuronal atrophy, impaired synaptic function, and increased vulnerability to neuroinflammation, exacerbating disease progression. Conversely, enhancing BDNF signaling has been shown to promote neuroprotection, improve cognitive function, and support recovery in animal models of neurodegeneration.
Understanding BDNF′s function and its involvement in neuroinflammation and neurodegenerative processes is crucial for developing therapeutic strategies aimed at enhancing BDNF signaling to improve outcomes for neurological disorders.
BDNF plays a significant role in neurological disorders and neurodegenerative diseases. Reduced levels of BDNF have been associated with conditions like Alzheimer′s disease, Parkinson′s disease, and depression. Low BDNF levels can lead to neuronal atrophy, impaired synaptic function, and increased vulnerability to neuroinflammation, exacerbating disease progression. Conversely, enhancing BDNF signaling has been shown to promote neuroprotection, improve cognitive function, and support recovery in animal models of neurodegeneration.
Understanding BDNF′s function and its involvement in neuroinflammation and neurodegenerative processes is crucial for developing therapeutic strategies aimed at enhancing BDNF signaling to improve outcomes for neurological disorders.
Features and Benefits
- Ultra-Sensitive Measurement: Accurately measures BDNF at femtogram/mL concentrations in serum, plasma, or CSF.
- Enhanced Signal Clarity: Improves the signal-to-noise ratio, minimizing background noise for consistent assay results.
- Intuitive Workflow: Employs a familiar sandwich immunoassay design, facilitating easy adoption for researchers trained in ELISA.
- Ready for Automation: Designed to integrate with automated liquid handling systems, streamlining processes and boosting laboratory productivity.
- Comprehensive Support: Supported by experienced field scientists and technical experts.
Packaging
96 well assay
Analysis Note
- Sensitivity: LLOQ 40 fg/mL* (SMCxPRO® Instrument)
- Standard Curve Range: 20-100,000 fg/mL
- Intra-assay CV: <10%
- Inter-assay CV: <15%
- Linearity: Serum: 85% Plasma: 102%
- Recovery: Serum: 90% Plasma: 96% CSF: 98%
*Indicative LLOQ created from average of 14 independent in house runs, where >80% met same value defined with CV & Recovery +/- 20%. Refer to CoA for lot specific performance.
NeuroscienceNeurological DisordersNeurotropins
Other Notes
Although BDNF was detectable in mouse, rat, non-human primate (rhesus macaque and cynomolgus monkey), and canine samples, the assay has not been verified for these species.
Legal Information
FEMTOQUEST is a trademark of Merck KGaA, Darmstadt, Germany
SMC is a registered trademark of Singulex
SMCxPRO is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - ED ENV 1 - Eye Irrit. 2 - Repr. 1B - STOT RE 2 Inhalation
target_organs
Respiratory Tract
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3